Unique gene signatures associated with drug-resistant leukaemia paves the way for improved clinical strategies to help these patients.
Researchers develop a protocol to boost the effectiveness of and reduce the risk of potential side effects for T cell cancer therapies.
Researchers have discovered a molecular pathway in colorectal cancer cells that leads to uncontrolled division, creating an avenue for more targeted therapies.
A new diagnostic innovation powered by artificial intelligence could empower surgeons to make more accurate and effective clinical decisions for colon cancer patients.
A T cell therapy innovation may offer new hope for acute myeloid leukemia patients who relapse after conventional treatment.
A*STAR researchers discover a mechanism that fires up the metabolism of cancer-killing immune cells, paving the way for future cancer immunotherapies.
A molecular tagging tool developed in Singapore identifies novel protein interactions on the surface of cancer cells.
Cancer genetics experts say new technologies and more comprehensive data collection are required to deepen our understanding of tumour lifecycles.
A novel polymer improves the effectiveness of chemotherapeutics against drug-resistant tumors.
A new biomarker in liver tumor may help doctors predict how patients respond to immunotherapy.
A genetic discovery reveals why some aggressive carcinomas do not respond to standard treatment and suggest a more effective option.